Cancer

Title Average Ratingsort descending
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer. 80.00%
Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer 80.00%
A prospective randomised controlled study of the use of ranitidine in patients with gastric cancer. Yorkshire GI Tumour Group. 80.00%
Anthroposophic health care--different and home-like. 80.00%
Resveratrol 80.00%
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients .... 80.00%
Death by Lockdown 80.00%
DR. MIKAEL NORDFORS INTERVIEWED BY SONIA POULTON 04.02.2022 80.00%
Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. 80.00%
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds 80.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative.. 80.00%
The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. 80.00%
Antitumor properties and modulation of antioxidant enzymes' activity by Aloe vera leaf active principles isolated via supercriti 80.00%
Effect of some isoquinoline alkaloids on enzymatic activity of acetylcholinesterase and monoamine oxidase 80.00%
Induction of apoptosis in cultured Chinese hamster ovary cells by Ukrain and its synergistic action with etoposide. 80.00%
The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking and 80.00%
Evaluation of anticancer activities of benzo phenanthridine alkaloid sanguinarine in oral squamous cell carcinoma cell line. 80.00%
Ukrain Debate 1: What is the active Substance of Ukrain? 80.00%
Possible association between nanobacteria and malignant microcalcifications in breast cancer. 80.00%
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. 80.00%
Interaction between Ukrain and Naltrexone in the writhing syndrome test in mice 80.00%
Clinical applications of magnetic nanoparticles for hyperthermia. 80.00%
The influence of glucose, succinate, pH of the medium and higher temperature on the cytotoxic activity of the preparation Ukrain 80.00%
66 year man. Cholangiocarcinoma 80.00%
National Cancer Institute, National Institute of Health: Developmental Therapeutics Program. NSC 631570: results of the Human Ce 80.00%
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. 80.00%
Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial. 80.00%
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. 80.00%
Dendritic cell vaccination in melanoma patients: Update and subgroup analysis of clinical response to post-vaccine treatment. 80.00%
Metformin induces unique biological and molecular responses in triple negative breast cancer cells. 80.00%
Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy 80.00%
Regional hyperthermia in high-risk soft tissue sarcomas. 80.00%
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to... 80.00%
Be prudent of ketamine in treating resistant depression in patients with cancer. 80.00%
Newcastle disease virus as an oncolytic agent. 80.00%
Cytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effect. 80.00%
High-dose medroxyprogesterone acetate versus estramustine in therapy-resistant prostatic cancer: a randomised study. 80.00%
The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. 80.00%
Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growt 80.00%
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. 80.00%
Clinical studies of Ukrain in terminal cancer patients (phase II) 80.00%
Clinical experience of integrative cancer immunotherapy with GcMAF. 80.00%
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. 80.00%
Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled 80.00%
Complementary and alternative medicines taken by cancer patients 80.00%
Boswellic acids: biological actions and molecular targets. 80.00%
Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate ca 80.00%
The effect of whole-body hyperthermia combined with 'metronomic' chemotherapy on rat mammary adenocarcinoma metastases. 80.00%
Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. 80.00%
Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocy.. 80.00%
Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour ce 80.00%
The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 ... 80.00%
Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma 80.00%
Ukrain therapy of recurrent breast cancer with lung metastases (case report) 80.00%
Melatonin as biological response modifier in cancer patients. 80.00%
Ukrain acts by inhibition of tubulin polymerization in normal and malignant cell lines. 80.00%
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse 80.00%
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) 80.00%
Activity of a multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen in metastatic renal cell carcinoma (m 80.00%
Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecula 80.00%
A phase II study of sorafenib in combination with tegafur/uracil (UFT) for Asian patients with advanced hepatocellular carcinoma 80.00%
Vitamin D Binding Protein-Macrophage Activating Factor Inhibits HCC in SCID Mice. 80.00%
To widen the setting of cancer patients who could benefit from metronomic capecitabine. 80.00%
Bevacizumab for recurrent ependymoma. 80.00%
An Internet misadventure: bloodroot salve toxicity 80.00%
Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patient 80.00%
Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. 80.00%
Pilot study of a specific dietary supplement in tumor-bearing mice and in stage IIIB and IV non-small cell lung cancer patients. 80.00%
The antimitotic effects of Ukrain, a Chelidonium majus alkaloid derivative, are reversible in vitro. 80.00%
Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expressio 80.00%
82 year old woman. Breast cancer with lymph and bone metastasis. 80.00%
Ukrain monotherapy in malignant melanoma (case report) 80.00%
A lipoxygenase inhibitor in breast cancer brain metastases. 80.00%
Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. 80.00%
Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer 80.00%
Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy. 80.00%
Hypericine 83.33%
Mistletoe Therapy in Cancer 83.33%
82 year old man with prostate cancer 85.00%
Curcumin 85.00%
Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. 85.00%
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial 85.00%
The anti-angiogenic basis of metronomic chemotherapy. 85.00%
Adjuvant vaccination with melanoma antigen pulsed dendritic cells (DCs) in stage III melanoma patients. 85.00%
Todoxin, the immune stimulant from Serbia 86.36%
Systems biology: a therapeutic target for tumor therapy. 86.67%
GcMAF-The cancer revolution from Japan 87.50%
Low dose "Metronomic" Chemotherapy 89.00%
The PEP-C regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy. 90.00%
Randomized Trials of Selenium, Vitamin E, or Vitamin C for Prostate Cancer Prevention 90.00%
A randomized trial of personalized peptide vaccine (PPV) plus low-dose estramustine (EMP) versus full-dose EMP in patients ..... 90.00%
Immunomodulatory effects of opioids. 90.00%
RECURRENCE OF BRAIN TUMORS MAY BE PREVENTED WITH RUTA AND CALCAREA PHOSPHORICA 90.00%
Current perspectives on the medicinal potentials of Vernonia amygdalina Del. 90.00%
61 year old woman, Breast cancer with lymph, and lung metastasis 90.00%
A homeopathic approach to treat patients with advanced gallbladder, periampullary, and liver carcinomas: a report of 3 cases. 90.00%
Mycoplasma infections and different human carcinomas. 90.00%
Electromagnetic energy as a bridge between atomic and cellular levels in the genetics approach to cancer treatment. 90.00%
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. 90.00%
Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prosta 90.00%

Pages